thumbnail image
  • Home
  • Who We Are  
    • Our Mission
    • Our Team
    • Subsidiary
  • Tech & Science  
    • Core Technologies
    • Clinical Trials
  • Products  
    • VRAT™
    • HFS™ / FocusEDTx™
  • News & Activities
  • Contact Us  
    • For Parents
    • For Clinicians
    • For Educators
    • Join Our Team
  •  

    Walter Greenleaf, Ph.D.

    Advisor, Co-Founder

     

     

    Walter Greenleaf is a Co-Founder at Cognitive Leap. With over three decades of research and development experience, Walter is considered a leading authority in the field of digital medicine and medical virtual reality technology. Walter has designed and developed clinical systems over the last thirty-five years for use in both physical and cognitive medicine, specifically focusing on the use of virtual reality technology.

     

    Walter is the Co-founder and Board Chair for the International Virtual Reality Health Association (IVRHA). He is a Distinguished Visiting Scholar at Stanford’s mediaX, Director of the National Mental Health Innovation Center at the University of Colorado, and co-founder and board chair of the Virtual Reality-Immersive Technology Clinic at Stanford Healthcare. Walter has founded several successful medical product companies and maintains dual roles in academics and business – lecturing, conducting research and publishing, while concurrently developing and bringing medical products to market.

     

    Walter served as CEO and founder of InWorld Solutions, a company specializing in the therapeutic use of virtual worlds for behavioral healthcare, as well as Virtually Better, a company that develops virtual environments for the treatment of phobias, anxiety disorders and PTSD. Walter has a Ph.D in Neuro and Bio-Behavioral Sciences from the Stanford University School of Medicine, where he was awarded a National Institute of Mental Health Graduate Fellowship.

© 2022. Cognitive Leap Solutions Inc.

    All Posts
    ×
    Cookie Use
    We use cookies to ensure a smooth browsing experience. By continuing we assume you accept the use of cookies.
    Learn More